-

Sir Andrew Witty Returns to UnitedHealth Group After Leave of Absence

MINNETONKA, Minn.--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) announced that Sir Andrew Witty, president of UnitedHealth Group and chief executive officer of Optum, has returned to the company after an eight-month leave of absence to serve as a Global Envoy for the World Health Organization’s COVID-19 efforts. Witty will resume his duties effective immediately.

About UnitedHealth Group

UnitedHealth Group (NYSE: UNH) is a diversified health care company dedicated to helping people live healthier lives and helping make the health system work better for everyone. UnitedHealth Group offers a broad spectrum of products and services through two distinct platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services. For more information, visit UnitedHealth Group at www.unitedhealthgroup.com or follow @UnitedHealthGrp on Twitter.

Contacts

Brett Manderfeld
Senior Vice President
952-936-7216

Media:
Eric Hausman
952-936-3963
eric.hausman@uhg.com

Industry:

UnitedHealth Group

NYSE:UNH
Release Summary
UnitedHealth Group announced that Sir Andrew Witty, president of UnitedHealth Group and chief executive officer of Optum, has returned to the company.
Release Versions
English

Contacts

Brett Manderfeld
Senior Vice President
952-936-7216

Media:
Eric Hausman
952-936-3963
eric.hausman@uhg.com

More News From UnitedHealth Group

Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors

--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group’s (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront t...

UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced that it recently became aware of an unsolicited “mini-tender” offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group’s common stock, representing significantly less than 1% of UnitedHealth Group’s common stock outstanding. The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group’s common stock exceeding $325.00 per share on the l...

UnitedHealth Group Announces Leadership Transition

--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty’s decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company’s Board of Directors and Witty will serve as a senior adviser to Hemsley. “We are grateful for Andrew’s stewardship of UnitedHealth Group, especially during some of the most cha...
Back to Newsroom